Macro FX trading Q4 2020 commentary

SaxoSelect Commentaries
Instruments tradedFX spot
Asset classesFX
Investment styleDiscretionary (non-systematic), macro analysis
Quarterly return (net of all fees*)12.4%
Annualised volatility20.1% 
Average trades per week13 

Market overview

Markets were driven by a multitude of key events  in Q4 2020:  the resurgence of high Covid 19 caseloads accelerating throughout the quarter, the US elections on 3rd November, successful conclusions of multiple Covid 19 vaccine trials and the path of Brexit negotiations to avoid ‘no deal’ and tariffs. Uncertainty and high implied risk volatility prices characterized the period leading up to said events with falls strongly contributing to positive risk flows in the aftermath. 


Strategy performance (net of all fees*)

Since inception (February 2015)

*Performance net of all fees represents the performance after all costs including transaction costs, product costs, the 0.5% annual service fee and the 20% performance fee on profits above the high water mark. The performance fee presented in this document assumes the investor has been invested since inception. Therefore, your performance fee is likely to differ, as you will only be charged we you make profit on your investment, above your high water mark.

**The estimated performance fee due for the quarter is deducted from December performance number, meaning the month’s performance would be greater without this performance fee incurred. In practice, your performance fee is deducted from your account in the first few days of the new quarter.

The strategy gained 12.8% during Q4 2020.  The book made positive returns on short USD, long AUD, NOK AND CHF positions early in October before switching to a short EUR-JPY position at the end of the month as uncertainties relating to the diminishing chance of more Covid stimulus, the result of the election and the potential conduct of President Trump after repeated claims he might contest the outcome on the grounds of perceived irregularities. 

A combination of a Biden victory, calm elections and positive vaccine news led to a pronounced November risk rally with strong participation from commodities and steeper yield curves as risks of contest receded and with the possibility of a Democratic senate control. 

In the aftermath the book made further gains on short USD positions against NOK, NZD as well as GBP and CHF and concluded the quarter with further gains on new long AUD-USD positions in December. 

Best-performing positions


Worst-performing positions



2021 has made a dramatic start to the year. The US Senate goes to the Democrats allowing decisive action on Fiscal Stimulus albeit with a razor thin majority which can temper extremities. The US rate market is stirring as it eyes the prospect of touted 2000 USD stimulus cheques (for households already long of excess savings) and anything up to 2 trillion USD more for a new Covid Relief Package. 

Long dated US interest rates are rising, with the 10 year rate breaching 1.10 and the 30 year closing in on 2 pct.  US Fed comments have flipped too with hints of Taper (of QE purchases) as early as 2021 when only last month the talk was of Fed capping yields to add more stimulus.  The Senate outcome is a potentially seismic event for Bonds and Rates and likewise various commodities (Copper, Silver) likely to feature in Bidens Green Deal. Key for the USD will be the extent to which rates are driven by rising inflation expectations vs potential Fed tightening of financial conditions. 

A reflationary environment favors a weaker USD, whereas Fed tightening favors a stronger USD and thus far the strategy manager which sees elements of both, keeps a very close eye on the interaction between 10 year nominal yields, inflation break-evens and real yields. The market starts the year consensus short USD, a factor potentially pertinent to other higher risk assets such as Emerging Market bonds and FX so their performance is also on the radar for possible feedback loops into developed market FX.  

The path of the virus is also a significant factor for markets. The UK has experienced a new aggressively contagious strain making for higher caseloads, harder, longer and economically costly lockdowns. The new variant is surfacing in various other countries. On the brighter side the UK caseloads may look to be peaking at the same time as the vaccine rollout makes good progress.  A hard Brexit was averted albeit with the skinniest of deals sidelining financial services amongst others.  Europe is lagging on the vaccine front, particularly France, which might translate into a longer and more costly lockdown.  


Any information found in this document, including performance information and statistics are subject to change. You can find the latest updated pricing information on the description page for each available portfolio. In providing this material Saxo Bank has not taken into account any particular recipient’s investment objectives, special investment goals, financial situation, and specific needs and demands and nothing herein is intended as a recommendation for any recipient to invest or divest in a particular manner and Saxo Bank assumes no liability for any recipient sustaining a loss from trading in accordance with a perceived recommendation. All investments entail a risk and may result in both profits and losses, and all capital is at risk. In particular investments in leveraged products, such as but not limited to foreign exchange, derivatives and commodities can be very speculative and profits and losses may fluctuate both violently and rapidly. Speculative trading is not suitable for all investors and all recipients should carefully consider their financial situation and consult financial advisors in order to understand the risks involved and ensure the suitability of their situation prior to making any investment, divestment or entering into any transaction. Any mentioning herein, if any, of any risk may not be, and should not be considered to be, neither a comprehensive disclosure of risks nor a comprehensive description of such risks. Any expression of opinion may not reflect the opinion of Saxo Bank and all expressions of opinion are subject to change without notice (neither prior nor subsequent).

Saxo Bank A/S (hovedkontor)
Philip Heymans Alle 15

Kontakt Saxo

Velg region


Kjenn risikoen
All handel innebærer risiko. Les mer. Derfor har vi utarbeidet en serie med nøkkelinformasjonsdokumenter (Key Information Document – KID) som forklarer hva slags risiko og gevinst som er knyttet til de enkelte produktene. Andre nøkkelinformasjonsdokumenter finner du på handelsplattformen vår. Les mer

Saxo Bank A/S er inkorporert i Danmark som en lisensiert bank (lisensnr. 1149) og er regulert av det danske Finanstilsynet, Århusgade 110, 2100, København Ø, Danmark.

Du kan se flere detaljer om Finanstilsynet og lisensen til Saxo Bank A/S på Som medlem av EU har Danmark inkorporert EU-direktivene for bank og investering i de danske lovene.